Advertisement

Picture Kentro Design Corporate and Web Design for Start Ups 2x 650x80px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 3757 | Ordered by Date (descending)
next pagenext page 1 2 3 4 ... 36 37 38  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Cytovation–SEVERAL: investment, 202201 financing round Series A NOK180m (€20m) led by Sandwater + Canica 2022-01-25
InstaDeep–BioNTech: investment, 202201 financing round Series B totalling $100m incl co-investor BioNTech 2022-01-25
InstaDeep–SEVERAL: investment, 202201 financing round Series B $100m led by Alpha Intelligence Capital with CDIB 2022-01-25
Metagenomi–Bayer: investment, 202201 financing round Series B totalling $175m incl existing + co-investor Leaps by Bayer 2022-01-25
Metagenomi–SEVERAL: investment, 202201 financing round Series B $175m co-led by PFM Health Sciences + Farallon Capital Mgt + NN 2022-01-25
Ferring–Cyprumed: drug delivery technology, 202201– collab expansion RnD for oral drug delivery of peptide therapeutics 2022-01-24
Elastrin Therapeutics–Forever Healthy: investment, 202201 existent investment of Kizoo 2022-01-21
Lift BioSciences–Forever Healthy: investment, 202201 financing round totalling £5m incl existing + co-investor Kizoo Technology Ventures 2022-01-21
Lift BioSciences–SEVERAL: investment, 202201 financing round £5m led by new investor Starbloom Capital 2022-01-21
Revel Pharmaceuticals–Forever Healthy: investment, 202201 existent investment of Kizoo 2022-01-21
Underdog–Forever Healthy: investment, 202201 existent investment of Kizoo 2022-01-21
Prolab Instruments–Bruker: investment, 202201 acquisition €na of Prolab Instruments Gmbh by Bruker 2022-01-19
Labiotech.eu–Inova Software: investment, 202201 acquisition by Inova 2022-01-18
PreOmics–Bruker: investment, 202201 acquisition €na of shares of HTGF + Think.Health Ventures + certain business angels by Bruker 2022-01-18
PreOmics–Bruker: investment, 202201 Series B investment €13.5m from Bruker tog w secondary transaction making Bruker majority shareholder 2022-01-18
ProtaGene–Ampersand: investment, 202201 existent portfolio company after merger/acquisition of PPS GmbH + BioAnalytix + GeneWerk GmbH in 7/21 2022-01-12
Temedica–MC Services: public relations, 202201 service existent PR + IR by MC Services 2022-01-12
Creoptix–Spectris: investment, 202201 acquisition of Creoptix AG by Malvern Panalytical 2022-01-11
Pantherna Therapeutics–High-Tech Gründerfonds: investment, 202201 follow-on financing round totalling €4m incl existing + co-lead investor HTGF 2022-01-11
Pantherna Therapeutics–PERSON: investment, 202201 follow-on financing round totalling €4m incl existing + co-lead investor Riesner Verwaltungs GmbH 2022-01-11
Pantherna Therapeutics–SEVERAL: investment, 202201 follow-on financing round €4m led by existing investors Detlev Riesner + HTGF 2022-01-11
BioNTech–Crescendo Biologics: antibody technology, 202201–202512 collab ww up to $790m + royalties using Humabody VH platform for BioNTech targets 2022-01-10
Crescendo Biologics–BioNTech: investment, 202201 equity investment €na as part of €40m collab upfront payment with cash + equity investment 2022-01-10
Exelead–Merck (DE): investment, 202201 acquisition $760m in cash by Merck 2022-01-06
BioNTech–Pfizer: investment, 202201 equity investment $150m by Pfizer in connection with shingles vaccine collaboration 2022-01-05
Pfizer–BioNTech: mRNA-based vaccines, 202201– collab developm $50m net cash upfront shingles vaccine with shared development cost + profits 2022-01-05
ALS Automated Lab Solutions–Sartorius: investment, 202201–2026 acquisition of 62.5% share in ALS with remaining share to be acquired in 2026 2022-01-03
Evolva–Nice & Green: credit, 202112–202312 convertible notes financing with incremental lines up to max of CHF12m principal amount 2021-12-27
Grand Pharma–ITM: radiopharmaceutical, 202112– license excl dev + production + commerc of ITM-11 + ITM-41 + TOCscan in Greater China 2021-12-27
Gyroscope Therapeutics–Novartis: investment, 202112– acquisition $800m upfront + $700m milestones by Novartis ANNOUNCED 2021-12-22
Thuja Capital–SEVERAL: investment, 202112 final closing of Thuja Capital Heathcare Fund III at €76m incl investor EIF 2021-12-21
Chord Therapeutics–Merck (DE): investment, 202112– acquisition of Chord by Merck KGaA from sole investor Omega Funds 2021-12-20
Anaveon–Cowen: investment, 202112 financing round Series B totalling CHF110m incl new + co-investor Cowen Healthcare Investments 2021-12-16
Anaveon–Forbion: investment, 202112 financing round Series B totalling CHF110m incl new + lead investor Forbion 2021-12-16
Anaveon–JW Communications: public relations, 202112 service existent by JW Communications 2021-12-16
Anaveon–Novartis: investment, 202112 financing round Series B totalling CHF110m incl existing + co-investor Novartis Venture Fund 2021-12-16
Anaveon–Pfizer: investment, 202112 financing round Series B totalling CHF110m incl new + co-investor Pifzer Ventures 2021-12-16
Anaveon–Pontifax: investment, 202112 financing round Series B totalling CHF110m incl new + co-investor Pontifax 2021-12-16
Anaveon–SEVERAL: investment, 202112 financing round Series B CHF110m with new + lead investor Forbion 2021-12-16
Anaveon–Syncona: investment, 202112 financing round Series B totalling CHF110m incl existing + co-lead investor Syncona 2021-12-16
Brainomix–Boehringer: investment, 202112 financing round Series B totalling £16m incl existing + co-lead investor BIVF 2021-12-16
Brainomix–SEVERAL: investment, 202112 financing round Series B £16m co-led by existing investors BIVF + Parkwalk Advisors 2021-12-16
Evotec–Gates Foundation: grant, 202112– grant $18m for drug r+d in area of women’s health + contraceptive technology 2021-12-16
Patronus Health–Hessen (govt): grant, 202112 public grant from State of Hesse 2021-12-16
Patronus Health–MC Services: public relations, 202112 service existent by MC Services 2021-12-16
Patronus Health–SEVERAL: investment, 202112 pre-seed financing round led by business angel Georg Matheis 2021-12-16
Lonza–Agilent: analytical instruments, 202112– strategic alliance to integrate analytical technologies in Cocoon cell therapy production platform 2021-12-15
BMS–Immatics: TCR Bispecific, 202112– license ww excl $150m upfront + $770m milestones + royalties to IMA401 programme 2021-12-14
Novartis–Molecular Partners: DARPins, 202112– collab $20m upfront + $560m milestones + royalties license to develop + manuf + commerc DARPin-RLTs 2021-12-14
Vifor Pharma–CSL: investment, 202112– cash tender offer CHF10.9b ($11.7b) at CHF167/share ANNOUNCED 2021-12-14
Memo Therapeutics–Switzerland (govt): grant, 202112– FOPH grant CHF10.5m for clinical developm of SARS-CoV-2 antibody COVAB 36 2021-12-13
deepCDR Biologics–Alloy Therapeutics: investment, 202112 acquisition of deepCDR Biologics by Alloy 2021-12-09
Forbion European Acquisition Corporation–SEVERAL: investment, 202112 SPAC US IPO $110m with 11m units at $10/unit 2021-12-09
Aleph Farms–Wacker: cell culture media, 202112– collab developm production process for growth-medium proteins for cultured meat 2021-12-08
Merck (DE)–Merck (DE): investment, 202112 third increase of financial commitment by €600m in evergreen corporate venture fund M Ventures 2021-12-08
Emergence Therapeutics–SEVERAL: investment, 202112 financing round Series A €87m led by Pontifax Venture Capital 2021-12-07
Freenome–HBM: investment, 202112 financing round Series D totalling $300m incl new + co-investor HBM Healthcare Investments 2021-12-07
Freenome–Novartis: investment, 202112 financing round Series D totalling $300m incl existing + co-investor Novartis 2021-12-07
Freenome–Roche: investment, 202112 financing round Series D totalling $300m incl existing + co-investor Roche Venture Fund 2021-12-07
Freenome–SEVERAL: investment, 202112 financing round Series D $300m co-led by Perceptive Advisors + RA Capital Management 2021-12-07
Freenome–Siemens: breast cancer diagnostics, 202112– collab research using imaging + multi-omics to identify markers for early detection 2021-12-07
Odyssey Therapeutics–HBM: investment, 202112 financing round Series A totalling $218m incl co-investor HBM Healthcare Investments 2021-12-07
Odyssey Therapeutics–SEVERAL: investment, 202112 financing round Series A $218m led by OrbiMed Advisors + co-led by SR One 2021-12-07
Quay Pharmaceuticals–SGS: investment, 202112 acquisition of Quay Pharma by SGS 2021-12-07
Roche–Recursion Pharmaceuticals: AI-based drug discovery, 202112– strategic collab $150m upfront up to 40 programs to be selected by Roche+Genentech 2021-12-07
Novartis–UCB: Parkinson drugs, 202112– collab up to $1.5b with $150m upfront ww developm + commercialisation of UCB0599 + option for UCB7853 2021-12-02
Origimm Biotechnology–Sanofi: investment, 202112– acquisition by Sanofi SIGNED 2021-12-01
SciRhom–High-Tech Gründerfonds: investment, 202111 existent HTGF is existing seed investor 2021-11-30
SciRhom–SEVERAL: investment, 202111 seed financing round extension €8m bringing total funding to €16m 2021-11-30
Dermagnostix–SEVERAL: investment, 202111 7-digit € seed financing round 2021-11-26
Lindera–SEVERAL: investment, 202111 financing round Series A €6m incl new investor family office zwei.7 2021-11-25
Lindera–Wulf Group: investment, 202111 financing round Series A totalling €6m incl new investor family office zwei.7 2021-11-25
Relief Therapeutics–BioXcel: AI-based drug discovery, 202111– strategic collab €na using AlphaMeld platform of InveniAI for drug discovery 2021-11-24
Innerspace–Austria (govt): investment, 202111 2nd seed financing round totalling 7-digit € incl new investor aws Gründerfonds 2021-11-23
Innerspace–High-Tech Gründerfonds: investment, 202111 2nd seed financing round totalling 7-digit € incl existing investor HTGF 2021-11-23
Innerspace–MAD Ventures: investment, 202111 2nd seed financing round totalling 7-digit € incl existing investor MAD Ventures GmbH 2021-11-23
Innerspace–SEVERAL: investment, 202111 2nd seed financing round 7-digit € with MAD Ventures + HTGF + aws Gründerfonds 2021-11-23
LoQus23 Therapeutics–Novartis: investment, 202111 extended seed financing round totalling £7m incl new investor NVF 2021-11-23
LoQus23 Therapeutics–SEVERAL: investment, 202111 extended seed financing round £7m from founding investor DDF + new investor NVF 2021-11-23
Inositec–Vifor Pharma: investment, 202211 acquisition 100% for CHF20m upfront + low triple digit million milestones 2021-11-22
Sanifit–Vifor Pharma: investment, 202211 acquisition 100% for €205m upfront + €170m precommercial milestones + rgoressive commercial milestones 2021-11-22
Molecubes–Bruker: investment, 202111 acquisition €na by Bruker 2021-11-19
Axel Semrau–Trajan: investment, 202111 acquisition €19.85m by Trajan Group 2021-11-18
Bruker–Bico: MS-based single cell proteomics, 202111– co-marketing of Cellenion’s cellenONE with timsTOF SCP mass spectrometers 2021-11-15
Thermo Fisher–Bico: MS-based single cell proteomics, 202111– co-marketing Cellenion’s cellenONE + proteoCHIP with Orbitrap MS systems + TMT technology 2021-11-15
Nuritas–ECBF: investment, 202111 financing round Series B totalling $45m incl $7m from ECBF 2021-11-11
Nuritas–SEVERAL: investment, 202111 financing round Series B $45m led by Cleveland Avenue + incl ECBF 2021-11-11
Life Sciences Partners–EQT: investment, 202111–202202 acquisition €450m upfront with €112.5m in cash + €337.5m in shares plus €25m milestones 2021-11-10
Nebula Biocides–High-Tech Gründerfonds: investment, 202111 seed financing round totalling €1.6m incl investor HTGF 2021-11-10
Nebula Biocides–Mecklenburg-Vorpommern (govt): investment, 202111 seed financing round totalling €1.6m incl investor MBMV 2021-11-10
Nebula Biocides–OTHER: investment, 202111 seed financing round totalling €1.6m incl strategic investor operating in cleaning + disinfection equipment 2021-11-10
Nebula Biocides–SEVERAL: investment, 202111 seed financing round €1.6m from HTGF + MBMV + undisclosed strategic investor 2021-11-10
Develco Pharma–SHS: investment, 202111 existent portfolio company of SHS 2021-11-09
PathoQuest–SEVERAL: investment, 202111 financing round Series B up to €15m led by new investor SHS Capital 2021-11-09
PathoQuest–SHS: investment, 202111 financing round Series B totalling up to €15m incl new + lead investor SHS Capital 2021-11-09
PathoQuest–Verve Capital Partners: investment, 202111 financing round Series B totalling up to €15m incl existing + co-investor Verve Ventures 2021-11-09
PhagoMed–BioNTech: investment, 202111 acquisition estimated €150m of PhagoMed by BioNTech 2021-11-09
Phenox–SHS: investment, 202111 existent portfolio company of SHS 2021-11-09
GlycoEra–5AM Ventures: investment, 202111 financing round Series A totalling CHF45m incl co-lead investor 5AM Ventures 2021-11-05
GlycoEra–LimmaTech Biologics: investment, 202111 financing round Series A totalling CHF45m incl co-investor LimmaTech Biologics 2021-11-05
next pagenext page 1 2 3 4 ... 36 37 38  next pagenext page



Advertisement

Picture [iito] No Content Marketing 650x100px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x300px

» top